Based on the evidence presented, taken together with published activity of MERTK in immunosuppressive signaling following engagement of appropriately opsonized apoptotic cells (via GAS6 and PROS1), we suggest that interactions between apoptotic lymphoma cells and MERTK-expressing stromal/immune cells of the tumor lie at the root of the mechanism. The gene discussed is MERTK; the disease is neoplasm.